Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
TECK$59.05+0.15(+0.25%)Teck Provides Update on Highland Valley Copper Operations[3:18:56 PM ET]AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

LOT · NASDAQ

Lotus Technology Inc. American Depositary Shares

$0.50 0.00 (-0.02%)

Company overview

Lotus Technology Inc. engages in the design, development, and sale of sports luxury lifestyle battery electric vehicles. It offers electric sports car models, including Eletre and Emeya. The company is based in Shanghai, China.

Sector
Consumer Cyclical
Industry
Auto - Manufacturers
Exchange
NASDAQ
Market cap
$323M
Employees
1,996
Headquarters
Shanghai
Website
group-lotus.com
CEO
Qingfeng Feng
Listed
January 27, 2016
P/E
-0.70
Dividend yield
0.00%

Company financials

Revenue
$520M
Gross profit
$45.2M
Operating income
-$372M
EBITDA
-$331M
Net income
-$465M
EPS
-$0.71
Total assets
$2B
Total debt
$1.8B
Gross margin
8.70%
Net margin
-89.51%
Earnings yield
-142.00%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

0.430.731.021.311.60
LOT 1D NASDAQ O0.50H0.50L0.48C0.50-0.00 (-0.02%)Vol3.48K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
LOT Press release Lotus and WasabiCard Explored Enterprise‑Driven Stablecoin Payment Use‑Cases during TOKEN2049 Singapore GlobeNewswire
LOT Stock news Lotus Technology Q2 Earnings Call Highlights Defense World
LOT Stock news China EV Maker Lotus Posts Smaller Loss; Stock Climbs 5% Forbes
LOT Stock news Lotus Technology Inc. (LOT) Q2 2026 Earnings Call Transcript Seeking Alpha
LOT Stock news Lotus Technology Q2 Earnings Call Highlights MarketBeat
LOT Press release Lotus Technology Reports Unaudited Half Year 2026 Financial Results GlobeNewsWire
LOT Press release Lotus Tech Completed Acquisition of 100% Equity Interest of Lotus Advance Technologies, Integrating All Businesses and Operations Under One Lotus GlobeNewsWire
LOT Press release Lotus Technology to Report Unaudited First Half 2026 Financial Results on Thursday, August 27 GlobeNewsWire
LOT Stock news Lotus Technology (NASDAQ:LOT) Shares Gap Up – Here’s What Happened Defense World
LOT Press release Lotus Emeya Sets New Electric Vehicle Lap Record at Malaysia's Sepang International Circuit GlobeNewsWire
LOT Press release Lotus Tech Announces Change to Board Composition GlobeNewsWire
LOT Stock news Lotus opens orders for Eletre X in mainland Europe Globe News Wire
LOT Press release Lotus opens orders for Eletre X in mainland Europe GlobeNewsWire
LOT Press release Emira 420 Sport: the lightest and most powerful Emira yet GlobeNewsWire
LOT Stock news Lotus CEO warns solid-state batteries still up to a decade from mass production CNBC
LOT Press release Lotus Technology Inc. to Attend and Present at the LD Micro Invitational XVI on May 18-19th, 2026 Newsfile Corp
LOT Stock news Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar Globe News Wire
LOT Press release Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar GlobeNewsWire
LOT Stock news LOT Polish Airlines says Boeing hid 737 MAX safety concerns to sell jets Reuters
LOT Stock news Lotus Technology Inc. (LOT) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript Seeking Alpha
See more
FAQ

Questions about Lotus Technology Inc. American Depositary Shares

What does Lotus Technology Inc. American Depositary Shares do?
Lotus Technology Inc. engages in the design, development, and sale of sports luxury lifestyle battery electric vehicles. It offers electric sports car models, including Eletre and Emeya. The company is based in Shanghai, China.
What is LOT's market cap?
Lotus Technology Inc. American Depositary Shares (LOT) is a listed stock with a live quote. The latest market cap on this page is $323M.
Where is Lotus Technology Inc. American Depositary Shares headquartered?
Lotus Technology Inc. American Depositary Shares is headquartered in Shanghai.
How do I get LOT news from the API?
Call GET /v1/news?tickers=LOT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does LOT news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for LOT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the LOT price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs